Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05646056 · ClinicalTrials.gov registry record
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
A clinical trial, sponsored by Prolaio.
- Completed
- Registry status
- 82
- Enrollment target
NCT05646056 is a clinical trial that has completed, run by Prolaio. The registered enrollment target is 82 participants.
The verdict
NCT05646056 has completed, sponsored by Prolaio.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.
Interventions
- DEVICE Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2022-10-28 |
| Est. Completion | 2024-09-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05646056
The ClinicalTrials.gov registry entry for NCT05646056 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prolaio, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Software is the first listed.
NCT05646056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05646056 about?
NCT05646056 is a clinical study titled "A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk". This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.
What is the current status of trial NCT05646056?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2022-10-28. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT05646056?
The interventions under investigation include: Software (DEVICE).
Who is sponsoring clinical trial NCT05646056?
This trial is sponsored by Prolaio, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.